Home / Companies / Labcorp Drug Development Inc / Trends
Labcorp Drug Development Inc H-1B trends
Quarterly LCA aggregate trend points for Labcorp Drug Development Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2021 Q4 | 21 | 13 | 6 | $111,874 | $102,761 | 17 | 81.0% |
| 2022 Q1 | 13 | 7 | 3 | $113,937 | $108,992 | 13 | 100.0% |
| 2022 Q2 | 11 | 7 | 6 | $119,897 | $116,732 | 10 | 90.9% |
| 2022 Q3 | 18 | 13 | 7 | $115,750 | $108,198 | 18 | 100.0% |
| 2022 Q4 | 6 | 5 | 4 | $134,980 | $120,526 | 6 | 100.0% |
| 2023 Q1 | 9 | 5 | 3 | $104,288 | $103,321 | 9 | 100.0% |
| 2023 Q2 | 20 | 10 | 4 | $109,035 | $106,983 | 20 | 100.0% |
| 2023 Q3 | 6 | 6 | 6 | $103,574 | $100,686 | 6 | 100.0% |
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=labcorp+drug+development+inc&metric=lca_countJSON